Fortress Biotech, Inc. (FBIO)
1.95
+0.02
(+1.04%)
USD |
NASDAQ |
Oct 28, 16:00
1.95
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Total Return Price : 1.95 for Oct. 28, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 27, 2026 | 1.93 |
| October 26, 2026 | 1.87 |
| October 23, 2026 | 1.93 |
| October 22, 2026 | 1.99 |
| October 21, 2026 | 1.94 |
| October 20, 2026 | 1.94 |
| October 19, 2026 | 1.87 |
| October 16, 2026 | 1.87 |
| October 15, 2026 | 1.91 |
| October 14, 2026 | 1.90 |
| October 13, 2026 | 1.95 |
| October 12, 2026 | 2.11 |
| October 09, 2026 | 2.135 |
| October 08, 2026 | 2.09 |
| October 07, 2026 | 2.04 |
| October 06, 2026 | 2.05 |
| October 05, 2026 | 2.09 |
| October 02, 2026 | 2.03 |
| October 01, 2026 | 2.07 |
| September 30, 2026 | 2.14 |
| September 29, 2026 | 2.20 |
| September 28, 2026 | 2.17 |
| September 25, 2026 | 2.28 |
| September 24, 2026 | 2.28 |
| September 23, 2026 | 2.34 |
| Date | Value |
|---|---|
| September 22, 2026 | 2.45 |
| September 21, 2026 | 2.41 |
| September 18, 2026 | 2.51 |
| September 17, 2026 | 2.51 |
| September 16, 2026 | 2.46 |
| September 15, 2026 | 2.49 |
| September 14, 2026 | 2.53 |
| September 11, 2026 | 2.52 |
| September 10, 2026 | 2.57 |
| September 09, 2026 | 2.63 |
| September 08, 2026 | 2.71 |
| September 04, 2026 | 2.72 |
| September 03, 2026 | 2.71 |
| September 02, 2026 | 2.73 |
| September 01, 2026 | 2.68 |
| August 31, 2026 | 2.735 |
| August 28, 2026 | 2.77 |
| August 27, 2026 | 2.80 |
| August 26, 2026 | 2.81 |
| August 25, 2026 | 2.83 |
| August 24, 2026 | 2.93 |
| August 21, 2026 | 2.87 |
| August 20, 2026 | 2.77 |
| August 19, 2026 | 2.85 |
| August 18, 2026 | 2.91 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 0.93 |
| Kura Oncology, Inc. | 10.73 |
| Spero Therapeutics, Inc. | 1.17 |
| ACADIA Pharmaceuticals, Inc. | 20.30 |
| Alnylam Pharmaceuticals, Inc. | 232.44 |